글로버스메디컬(주)
MX ˙ BMV ˙ US3795772082
SecurityMX:GMED / Globus Medical, Inc.
InstitutionFox Run Management, L.l.c.
Latest Disclosed Ownership2,548 shares
Latest Disclosed Value $ 212,783
Fox Run Management, L.l.c. ownership in GMED / Globus Medical, Inc.

On May 12, 2026 - Fox Run Management, L.l.c. filed a 13F-HR form disclosing ownership of 2,548 shares of Globus Medical, Inc. (MX:GMED) valued at $212,783 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 13, 2024 disclosing 0 shares of Globus Medical, Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F GLOBUS MED CL A 379577208 2,548 2,548 213 0.0372
2024-08-13 2024-06-30 13F GLOBUS MED CL A 379577208 0 -19,957 -100.00 0 -100.00
2024-05-13 2024-03-31 13F GLOBUS MED CL A 379577208 19,957 19,957 1,070 0.2308
2023-08-11 2023-06-30 13F GLOBUS MED CL A 379577208 0 -12,973 -100.00 0 -100.00
2023-05-12 2023-03-31 13F GLOBUS MED CL A 379577208 12,973 12,973 735 0.2393
2022-02-09 2021-12-31 13F GLOBUS MED CL A 379577208 0 -3,974 -100.00 0 -100.00
2021-11-15 2021-09-30 13F GLOBUS MED CL A 379577208 3,974 3,974 304 0.1915
2021-05-17 2021-03-31 13F GLOBUS MED CL A 379577208 0 -6,413 -100.00 0 -100.00
2021-02-08 2020-12-31 13F GLOBUS MED CL A 379577208 6,413 6,413 418 0.8441
2020-05-08 2020-03-31 13F GLOBUS MED CL A 379577208 0 -5,407 -100.00 0 -100.00
2020-02-14 2019-12-31 13F GLOBUS MED CL A 379577208 5,407 1,341 32.98 318 52.88 0.2560
2019-10-15 2019-09-30 13F/A-1 GLOBUS MED CL A 379577208 4,066 4,066 208 0.1893
2019-07-17 2019-06-30 13F GLOBUS MED CL A 379577208 0 0 0 0.0000
2019-10-17 2019-03-31 13F GLOBUS MED CL A 379577208 0 -12,099 -100.00 0 -100.00
2019-01-15 2018-12-31 13F GLOBUS MED CL A 379577208 12,099 12,099 524 0.2776
2018-07-17 2018-06-30 13F GLOBUS MED CL A 379577208 0 -8,738 -100.00 0 -100.00
2018-04-17 2018-03-31 13F GLOBUS MED CL A 379577208 8,738 8,738 435 0.1055
2016-10-12 2016-09-30 13F GLOBUS MED CL A 379577208 0 -20,100 -100.00 0 -100.00
2016-07-18 2016-06-30 13F GLOBUS MED CL A 379577208 20,100 100 0.50 479 0.84 0.2326
2016-04-18 2016-03-31 13F GLOBUS MED CL A 379577208 20,000 20,000 475 0.3175
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.